Rocket Pharmaceuticals, Inc. (RCKT) vs X4 Pharmaceuticals, Inc. (XFOR)
- Rocket Pharmaceuticals, Inc. RCKT 2.18 −7.63%
- X4 Pharmaceuticals, Inc. XFOR 2.59 −1.89%
Rocket Pharmaceuticals, Inc. and X4 Pharmaceuticals, Inc. are both Biotechnology companies. Rocket Pharmaceuticals, Inc. and X4 Pharmaceuticals, Inc. are of similar size ($261.8M and $259.1M). Rocket Pharmaceuticals, Inc. has the higher net margin (0.00% vs −568.8%) and the higher return on invested capital (−114.7% vs −226.6%). Across the 14 metrics below, Rocket Pharmaceuticals, Inc. leads on 10 and X4 Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | RCKT | XFOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 81.51% | 65.16% |
| Operating margin | 0.00% | (554.71%) | 0.00% |
| Net margin | 0.00% | (568.80%) | 0.00% |
| Free cash flow margin | 0.00% | (559.95%) | 0.00% |
| Return on equity | (4.77%) | (113.08%) | (56.36%) |
| Return on assets | (4.09%) | (50.32%) | (48.04%) |
| Return on invested capital | (114.71%) | (226.62%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack